AllianceBernstein’s Y-mAbs Therapeutics YMAB Stock Holding History

AllianceBernstein’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$268K	Buy	59,380 +4,600	+8%	+$20.7K	﹤0.01%	2967
2025 Q1	$243K	Hold	54,780	–	–	﹤0.01%	2858
2024 Q4	$429K	Hold	54,780	–	–	﹤0.01%	2705
2024 Q3	$720K	Sell	54,780 -3,360	-6%	-$44.2K	﹤0.01%	2477
2024 Q2	$702K	Sell	58,140 -3,780	-6%	-$45.7K	﹤0.01%	2479
2024 Q1	$1.01M	Sell	61,920 -810	-1%	-$13.2K	﹤0.01%	2262
2023 Q4	$428K	Sell	62,730 -14,559	-19%	-$99.3K	﹤0.01%	2685
2023 Q3	$421K	Sell	77,289 -89,700	-54%	-$489K	﹤0.01%	2646
2023 Q2	$1.13M	Buy	166,989 +11,350	+7%	+$77.1K	﹤0.01%	2213
2023 Q1	$780K	Hold	155,639	–	–	﹤0.01%	2343
2022 Q4	$760K	Sell	155,639 -1,994,425	-93%	-$9.73M	﹤0.01%	2412
2022 Q3	$31M	Sell	2,150,064 -665,801	-24%	-$9.6M	0.02%	697
2022 Q2	$42.6M	Sell	2,815,865 -153,294	-5%	-$2.32M	0.02%	605
2022 Q1	$35.3M	Buy	2,969,159 +1,026,825	+53%	+$12.2M	0.01%	709
2021 Q4	$31.5M	Buy	1,942,334 +524,525	+37%	+$8.5M	0.01%	778
2021 Q3	$40.5M	Buy	1,417,809 +69,213	+5%	+$1.98M	0.02%	680
2021 Q2	$45.6M	Buy	1,348,596 +117,258	+10%	+$3.96M	0.02%	647
2021 Q1	$37.2M	Buy	1,231,338 +221,019	+22%	+$6.68M	0.02%	700
2020 Q4	$50M	Buy	1,010,319 +50,803	+5%	+$2.52M	0.02%	583
2020 Q3	$36.8M	Buy	959,516 +72,119	+8%	+$2.77M	0.02%	622
2020 Q2	$38.3M	Sell	887,397 -50,332	-5%	-$2.17M	0.02%	592
2020 Q1	$24.5M	Buy	937,729 +93,265	+11%	+$2.43M	0.02%	625
2019 Q4	$26.4M	Buy	844,464 +78,763	+10%	+$2.46M	0.02%	728
2019 Q3	$20M	Buy	765,701 +21,546	+3%	+$561K	0.01%	787
2019 Q2	$17M	Buy	744,155 +80,149	+12%	+$1.83M	0.01%	848
2019 Q1	$17.4M	Buy	664,006 +107,668	+19%	+$2.82M	0.01%	838
2018 Q4	$11.3M	Buy	556,338 +231,348	+71%	+$4.71M	0.01%	936
2018 Q3	$8.63M	Buy	+324,990	New	+$8.63M	0.01%	1016